scispace - formally typeset
N

Nazende Günday-Türeli

Publications -  6
Citations -  83

Nazende Günday-Türeli is an academic researcher. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 1, co-authored 2 publications receiving 50 citations.

Papers
More filters
Journal ArticleDOI

The solid progress of nanomedicine

TL;DR: The views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs) are conveyed.
Journal ArticleDOI

Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells.

TL;DR: In this paper , poly(lactide-co-glycolide) (PLGA) NPs coated with polysorbate 80 (PS80) and poloxamer 188 (P188) were tested on human pre-clinical in vitro model to evaluate and compare their uptake profiles, mechanisms of transport and crossing over human brain-like endothelial cells (BLECs) mimicking the human BBB.
Journal ArticleDOI

High-Throughput Method for the Simultaneous Determination of Doxorubicin Metabolites in Rat Urine after Treatment with Different Drug Nanoformulations

TL;DR: A high-throughput method based on high-performance liquid chromatography with fluorescence detection (HPLC-FD) for the quantification of DOX and its metabolites in the urine of laboratory animals after treatment with different DOX nanoformulations is developed.
Journal ArticleDOI

A scale-up strategy for the synthesis of chitosan derivatives used in micellar nanomedicines.

TL;DR: In this paper, two chitosan derivatives, methoxypolyethylene glycol-chitosans (mPEG-CS) and methoxymolyethylenes glycolchitosa-oleic acid, were implemented in a pharmaceutical industry to achieve the scale-up production using cross flow filtration (CFF).

Imaging mass spectrometry di ff erentiates the e ff ects of doxorubicin formulations on non-targeted tissues alterations, 6,7 biochemical assays

TL;DR: The IMS based procedure successfully di ff erentiated the eff ects of DOX nanoformulations on the model non-targeted tissue, thus indicating the importance of IMS in e fi ective drug development.